#ID(s) interactor A	ID(s) interactor B	Alt. ID(s) interactor A	Alt. ID(s) interactor B	Alias(es) interactor A	Alias(es) interactor B	Interaction detection method(s)	Publication 1st author(s)	Publication Identifier(s)	Taxid interactor A	Taxid interactor B	Interaction type(s)	Source database(s)	Interaction identifier(s)	Confidence value(s)	Expansion method(s)	Biological role(s) interactor A	Biological role(s) interactor B	Experimental role(s) interactor A	Experimental role(s) interactor B	Type(s) interactor A	Type(s) interactor B	Xref(s) interactor A	Xref(s) interactor B	Interaction Xref(s)	Annotation(s) interactor A	Annotation(s) interactor B	Interaction annotation(s)	Host organism(s)	Interaction parameter(s)	Creation date	Update date	Checksum(s) interactor A	Checksum(s) interactor B	Interaction Checksum(s)	Negative	Feature(s) interactor A	Feature(s) interactor B	Stoichiometry(s) interactor A	Stoichiometry(s) interactor B	Identification method participant A	Identification method participant B
uniprotkb:P0DTD1-PRO_0000449623	intact:EBI-25612655	intact:EBI-25475864	-	psi-mi:p0dtd1-pro_0000449623(display_long)|uniprotkb:rep(gene name)|psi-mi:rep(display_short)|uniprotkb:ORF1ab polyprotein(gene name synonym)|uniprotkb:1a-1b(orf name)	psi-mi:dabcyl-ktsavlqsgfrkme-edans(display_short)|psi-mi:EBI-25612655(display_long)	psi-mi:"MI:0435"(protease assay)	Jang et al. (2019)	pubmed:32963564|imex:IM-28397	taxid:2697049(SARS-CoV-2)|taxid:2697049(SARS-CoV-2)	taxid:-2(chemical synthesis)|taxid:-2("Chemical synthesis (Chemical synthesis)")	psi-mi:"MI:0570"(protein cleavage)	psi-mi:"MI:0469"(IntAct)	intact:EBI-26363315|imex:IM-28397-1	-	-	psi-mi:"MI:0501"(enzyme)	psi-mi:"MI:0502"(enzyme target)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0327"(peptide)	intact:EBI-25492095(chain-parent)|uniprotkb:P0DTD1(chain-parent)	pubmed:18583140(see-also)	go:"GO:0004197"(cysteine-type endopeptidase activity)	chain-seq-start:3264|chain-seq-end:3569	-	figure legend:Figure 2B, 3-7.|dataset:Virus - Publications including interactions involving viral proteins|dataset:Coronavirus - Interactions investigated in the context of Coronavirus|full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	-	2020/09/24	2020/10/02	rogid:9u1TJXDTORfCyqj2bv2TlDMZ65c2697049	rogid:5paWG8TKpS+Vdd4uWaMMBd0QUBk-2	rigid:AjyLX86/Ie8uYIiN31Zn33cnUmk	false	his tag:?-?	-	-	-	psi-mi:"MI:0867"(tag visualisation by fluorescence)	psi-mi:"MI:0867"(tag visualisation by fluorescence)
chebi:"CHEBI:4806"	intact:EBI-25612655	intact:EBI-10824768	-	psi-mi:"(-)-epigallocatechin 3-gallate"(display_short)|psi-mi:"CHEBI:4806"(display_long)|intact:"(-)-epigallocatechin-3-O-gallate"(synonym)|intact:"[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate"(synonym)|intact:EGCG(synonym)|intact:Epigallocatechin 3-gallate(synonym)|intact:"(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate"(iupac name)	psi-mi:dabcyl-ktsavlqsgfrkme-edans(display_short)|psi-mi:EBI-25612655(display_long)	psi-mi:"MI:0435"(protease assay)	Jang et al. (2019)	pubmed:32963564|imex:IM-28397	taxid:-2(chemical synthesis)|taxid:-2("Chemical synthesis (Chemical synthesis)")	taxid:-2(chemical synthesis)|taxid:-2("Chemical synthesis (Chemical synthesis)")	psi-mi:"MI:0570"(protein cleavage)	psi-mi:"MI:0469"(IntAct)	intact:EBI-26363330|imex:IM-28397-3	-	psi-mi:"MI:1060"(spoke expansion)	psi-mi:"MI:0586"(inhibitor)	psi-mi:"MI:0502"(enzyme target)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0328"(small molecule)	psi-mi:"MI:0327"(peptide)	-	pubmed:18583140(see-also)	go:"GO:0004197"(cysteine-type endopeptidase activity)	-	-	figure legend:Figure 3,5,6|inhibition:IC50 for EGCG of 7.58 ug/ml|comment:auto-oxidation products of EGCG reduce the inhibition.|dataset:Virus - Publications including interactions involving viral proteins|dataset:Coronavirus - Interactions investigated in the context of Coronavirus|full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	-	2020/09/24	2020/10/02	-	rogid:5paWG8TKpS+Vdd4uWaMMBd0QUBk-2	-	false	-	-	-	-	psi-mi:"MI:0867"(tag visualisation by fluorescence)	psi-mi:"MI:0867"(tag visualisation by fluorescence)
chebi:"CHEBI:4806"	uniprotkb:P0DTD1-PRO_0000449623	intact:EBI-10824768	intact:EBI-25475864	psi-mi:"(-)-epigallocatechin 3-gallate"(display_short)|psi-mi:"CHEBI:4806"(display_long)|intact:"(-)-epigallocatechin-3-O-gallate"(synonym)|intact:"[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate"(synonym)|intact:EGCG(synonym)|intact:Epigallocatechin 3-gallate(synonym)|intact:"(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate"(iupac name)	psi-mi:p0dtd1-pro_0000449623(display_long)|uniprotkb:rep(gene name)|psi-mi:rep(display_short)|uniprotkb:ORF1ab polyprotein(gene name synonym)|uniprotkb:1a-1b(orf name)	psi-mi:"MI:0435"(protease assay)	Jang et al. (2019)	pubmed:32963564|imex:IM-28397	taxid:-2(chemical synthesis)|taxid:-2("Chemical synthesis (Chemical synthesis)")	taxid:2697049(SARS-CoV-2)|taxid:2697049(SARS-CoV-2)	psi-mi:"MI:0570"(protein cleavage)	psi-mi:"MI:0469"(IntAct)	intact:EBI-26363330|imex:IM-28397-3	-	psi-mi:"MI:1060"(spoke expansion)	psi-mi:"MI:0586"(inhibitor)	psi-mi:"MI:0501"(enzyme)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0328"(small molecule)	psi-mi:"MI:0326"(protein)	-	intact:EBI-25492095(chain-parent)|uniprotkb:P0DTD1(chain-parent)	go:"GO:0004197"(cysteine-type endopeptidase activity)	-	chain-seq-start:3264|chain-seq-end:3569	figure legend:Figure 3,5,6|inhibition:IC50 for EGCG of 7.58 ug/ml|comment:auto-oxidation products of EGCG reduce the inhibition.|dataset:Virus - Publications including interactions involving viral proteins|dataset:Coronavirus - Interactions investigated in the context of Coronavirus|full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	-	2020/09/24	2020/10/02	-	rogid:9u1TJXDTORfCyqj2bv2TlDMZ65c2697049	-	false	-	his tag:?-?	-	-	psi-mi:"MI:0867"(tag visualisation by fluorescence)	psi-mi:"MI:0867"(tag visualisation by fluorescence)
intact:EBI-25612655	uniprotkb:P0DTD1-PRO_0000449623	-	intact:EBI-25475864	psi-mi:dabcyl-ktsavlqsgfrkme-edans(display_short)|psi-mi:EBI-25612655(display_long)	psi-mi:p0dtd1-pro_0000449623(display_long)|uniprotkb:rep(gene name)|psi-mi:rep(display_short)|uniprotkb:ORF1ab polyprotein(gene name synonym)|uniprotkb:1a-1b(orf name)	psi-mi:"MI:0435"(protease assay)	Jang et al. (2019)	pubmed:32963564|imex:IM-28397	taxid:-2(chemical synthesis)|taxid:-2("Chemical synthesis (Chemical synthesis)")	taxid:2697049(SARS-CoV-2)|taxid:2697049(SARS-CoV-2)	psi-mi:"MI:0570"(protein cleavage)	psi-mi:"MI:0469"(IntAct)	intact:EBI-26363339|imex:IM-28397-5	-	psi-mi:"MI:1060"(spoke expansion)	psi-mi:"MI:0502"(enzyme target)	psi-mi:"MI:0501"(enzyme)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0327"(peptide)	psi-mi:"MI:0326"(protein)	pubmed:18583140(see-also)	intact:EBI-25492095(chain-parent)|uniprotkb:P0DTD1(chain-parent)	go:"GO:0004197"(cysteine-type endopeptidase activity)	-	chain-seq-start:3264|chain-seq-end:3569	figure legend:Figure 4,5|inhibition:IC50 for EGCG of 8.44 ug/ml|dataset:Virus - Publications including interactions involving viral proteins|dataset:Coronavirus - Interactions investigated in the context of Coronavirus|full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	-	2020/09/24	2020/10/02	rogid:5paWG8TKpS+Vdd4uWaMMBd0QUBk-2	rogid:9u1TJXDTORfCyqj2bv2TlDMZ65c2697049	-	false	-	his tag:?-?	-	-	psi-mi:"MI:0867"(tag visualisation by fluorescence)	psi-mi:"MI:0867"(tag visualisation by fluorescence)
chebi:"CHEBI:136609"	intact:EBI-25612655	intact:EBI-26363348	-	psi-mi:theaflavin(display_short)|psi-mi:"CHEBI:136609"(display_long)|intact:"(-)-theaflavin"(synonym)|intact:"1,8-bis((2R,3R)-3,5,7-trihydroxy-2H-1-benzopyran-2-yl)-3,4,6-trihydroxy-5H-benzocyclohepten-5-one"(synonym)|intact:"1,8-bis(3-alpha,5,7-trihydroxy-2-alpha-chromanyl)-5H-benzocyclohepten-5-one"(synonym)|intact:"3,4,5-trihydroxy-1,8-bis[(2R,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]-6H-benzo[7]annulen-6-one"(synonym)|intact:theaflavine(synonym)|intact:"3,4,5-trihydroxy-1,8-bis[(2R,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]-6H-benzocyclohepten-6-one"(iupac name)	psi-mi:dabcyl-ktsavlqsgfrkme-edans(display_short)|psi-mi:EBI-25612655(display_long)	psi-mi:"MI:0435"(protease assay)	Jang et al. (2019)	pubmed:32963564|imex:IM-28397	taxid:-2(chemical synthesis)|taxid:-2("Chemical synthesis (Chemical synthesis)")	taxid:-2(chemical synthesis)|taxid:-2("Chemical synthesis (Chemical synthesis)")	psi-mi:"MI:0570"(protein cleavage)	psi-mi:"MI:0469"(IntAct)	intact:EBI-26363339|imex:IM-28397-5	-	psi-mi:"MI:1060"(spoke expansion)	psi-mi:"MI:0586"(inhibitor)	psi-mi:"MI:0502"(enzyme target)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0328"(small molecule)	psi-mi:"MI:0327"(peptide)	-	pubmed:18583140(see-also)	go:"GO:0004197"(cysteine-type endopeptidase activity)	-	-	figure legend:Figure 4,5|inhibition:IC50 for EGCG of 8.44 ug/ml|dataset:Virus - Publications including interactions involving viral proteins|dataset:Coronavirus - Interactions investigated in the context of Coronavirus|full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	-	2020/09/24	2020/10/02	-	rogid:5paWG8TKpS+Vdd4uWaMMBd0QUBk-2	-	false	-	-	-	-	psi-mi:"MI:0867"(tag visualisation by fluorescence)	psi-mi:"MI:0867"(tag visualisation by fluorescence)
chebi:"CHEBI:4806"	intact:EBI-25612655	intact:EBI-10824768	-	psi-mi:"(-)-epigallocatechin 3-gallate"(display_short)|psi-mi:"CHEBI:4806"(display_long)|intact:"(-)-epigallocatechin-3-O-gallate"(synonym)|intact:"[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate"(synonym)|intact:EGCG(synonym)|intact:Epigallocatechin 3-gallate(synonym)|intact:"(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate"(iupac name)	psi-mi:dabcyl-ktsavlqsgfrkme-edans(display_short)|psi-mi:EBI-25612655(display_long)	psi-mi:"MI:0435"(protease assay)	Jang et al. (2019)	pubmed:32963564|imex:IM-28397	taxid:-2(chemical synthesis)|taxid:-2("Chemical synthesis (Chemical synthesis)")	taxid:-2(chemical synthesis)|taxid:-2("Chemical synthesis (Chemical synthesis)")	psi-mi:"MI:0570"(protein cleavage)	psi-mi:"MI:0469"(IntAct)	intact:EBI-26363357|imex:IM-28397-7	-	psi-mi:"MI:1060"(spoke expansion)	psi-mi:"MI:0586"(inhibitor)	psi-mi:"MI:0502"(enzyme target)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0328"(small molecule)	psi-mi:"MI:0327"(peptide)	-	pubmed:18583140(see-also)	go:"GO:0004197"(cysteine-type endopeptidase activity)	-	-	figure legend:Figure 5|inhibition:"The calculated  CDI (coefficient of drug interaction) for EGCG and theaflavin = 0.93, indicating that EGCG and theaflavin had an additive rather than a synergistic effect."|dataset:Virus - Publications including interactions involving viral proteins|dataset:Coronavirus - Interactions investigated in the context of Coronavirus|full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	-	2020/09/24	2020/10/02	-	rogid:5paWG8TKpS+Vdd4uWaMMBd0QUBk-2	-	false	-	-	-	-	psi-mi:"MI:0867"(tag visualisation by fluorescence)	psi-mi:"MI:0867"(tag visualisation by fluorescence)
chebi:"CHEBI:4806"	uniprotkb:P0DTD1-PRO_0000449623	intact:EBI-10824768	intact:EBI-25475864	psi-mi:"(-)-epigallocatechin 3-gallate"(display_short)|psi-mi:"CHEBI:4806"(display_long)|intact:"(-)-epigallocatechin-3-O-gallate"(synonym)|intact:"[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate"(synonym)|intact:EGCG(synonym)|intact:Epigallocatechin 3-gallate(synonym)|intact:"(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate"(iupac name)	psi-mi:p0dtd1-pro_0000449623(display_long)|uniprotkb:rep(gene name)|psi-mi:rep(display_short)|uniprotkb:ORF1ab polyprotein(gene name synonym)|uniprotkb:1a-1b(orf name)	psi-mi:"MI:0435"(protease assay)	Jang et al. (2019)	pubmed:32963564|imex:IM-28397	taxid:-2(chemical synthesis)|taxid:-2("Chemical synthesis (Chemical synthesis)")	taxid:2697049(SARS-CoV-2)|taxid:2697049(SARS-CoV-2)	psi-mi:"MI:0570"(protein cleavage)	psi-mi:"MI:0469"(IntAct)	intact:EBI-26363357|imex:IM-28397-7	-	psi-mi:"MI:1060"(spoke expansion)	psi-mi:"MI:0586"(inhibitor)	psi-mi:"MI:0501"(enzyme)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0328"(small molecule)	psi-mi:"MI:0326"(protein)	-	intact:EBI-25492095(chain-parent)|uniprotkb:P0DTD1(chain-parent)	go:"GO:0004197"(cysteine-type endopeptidase activity)	-	chain-seq-start:3264|chain-seq-end:3569	figure legend:Figure 5|inhibition:"The calculated  CDI (coefficient of drug interaction) for EGCG and theaflavin = 0.93, indicating that EGCG and theaflavin had an additive rather than a synergistic effect."|dataset:Virus - Publications including interactions involving viral proteins|dataset:Coronavirus - Interactions investigated in the context of Coronavirus|full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	-	2020/09/24	2020/10/02	-	rogid:9u1TJXDTORfCyqj2bv2TlDMZ65c2697049	-	false	-	his tag:?-?	-	-	psi-mi:"MI:0867"(tag visualisation by fluorescence)	psi-mi:"MI:0867"(tag visualisation by fluorescence)
chebi:"CHEBI:4806"	chebi:"CHEBI:136609"	intact:EBI-10824768	intact:EBI-26363348	psi-mi:"(-)-epigallocatechin 3-gallate"(display_short)|psi-mi:"CHEBI:4806"(display_long)|intact:"(-)-epigallocatechin-3-O-gallate"(synonym)|intact:"[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate"(synonym)|intact:EGCG(synonym)|intact:Epigallocatechin 3-gallate(synonym)|intact:"(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate"(iupac name)	psi-mi:theaflavin(display_short)|psi-mi:"CHEBI:136609"(display_long)|intact:"(-)-theaflavin"(synonym)|intact:"1,8-bis((2R,3R)-3,5,7-trihydroxy-2H-1-benzopyran-2-yl)-3,4,6-trihydroxy-5H-benzocyclohepten-5-one"(synonym)|intact:"1,8-bis(3-alpha,5,7-trihydroxy-2-alpha-chromanyl)-5H-benzocyclohepten-5-one"(synonym)|intact:"3,4,5-trihydroxy-1,8-bis[(2R,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]-6H-benzo[7]annulen-6-one"(synonym)|intact:theaflavine(synonym)|intact:"3,4,5-trihydroxy-1,8-bis[(2R,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]-6H-benzocyclohepten-6-one"(iupac name)	psi-mi:"MI:0435"(protease assay)	Jang et al. (2019)	pubmed:32963564|imex:IM-28397	taxid:-2(chemical synthesis)|taxid:-2("Chemical synthesis (Chemical synthesis)")	taxid:-2(chemical synthesis)|taxid:-2("Chemical synthesis (Chemical synthesis)")	psi-mi:"MI:0570"(protein cleavage)	psi-mi:"MI:0469"(IntAct)	intact:EBI-26363357|imex:IM-28397-7	-	psi-mi:"MI:1060"(spoke expansion)	psi-mi:"MI:0586"(inhibitor)	psi-mi:"MI:0586"(inhibitor)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0328"(small molecule)	psi-mi:"MI:0328"(small molecule)	-	-	go:"GO:0004197"(cysteine-type endopeptidase activity)	-	-	figure legend:Figure 5|inhibition:"The calculated  CDI (coefficient of drug interaction) for EGCG and theaflavin = 0.93, indicating that EGCG and theaflavin had an additive rather than a synergistic effect."|dataset:Virus - Publications including interactions involving viral proteins|dataset:Coronavirus - Interactions investigated in the context of Coronavirus|full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	-	2020/09/24	2020/10/02	-	-	-	false	-	-	-	-	psi-mi:"MI:0867"(tag visualisation by fluorescence)	psi-mi:"MI:0867"(tag visualisation by fluorescence)